Physician

Rany Jazayerli, M.D.

According to 2025 Medicare claims, Rany Jazayerli, M.D. (NPI: 1831197995) practices dermatology in the Elgin, IL market, with the plurality of this provider's patient population coming from Kane, IL. This provider's primary affiliated billing organization is WEST SUBURBAN DERMATOLOGY & COSMETIC SURGERY (NPI: 1477617207; TIN: 020720473) and primary practice location at 60174-5797.

Jazayerli's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 929 traditional Medicare patients, billed 5,695 HCPCS/CPT codes, and received $250,110 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,590 prescription claims across 515 beneficiaries totaling $600,445 in drug costs, led by Otezla (Apremilast). Open Payments data shows 2 records totaling $48. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $127,319 to $250,110. Similarly, Part D prescription costs have risen steadily, from $43,698 to $600,445. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$140K$280K2015 Medicare payment: $127,319 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $184,974 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $185,037 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $213,931 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $279,863 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $190,104 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $249,619 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $267,234 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $260,874 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $250,110 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155422,972$127,319
20167074,835$184,974
20177895,209$185,037
20188245,354$213,931
20199846,833$279,863
20207744,631$190,104
20219085,466$249,619
20229445,783$267,234
20239495,841$260,874
20249295,695$250,110

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$300K$600K2015 Drug cost: $43,698 (USD; Tot_Drug_Cst)2016 Drug cost: $69,902 (USD; Tot_Drug_Cst)2017 Drug cost: $120,725 (USD; Tot_Drug_Cst)2018 Drug cost: $160,831 (USD; Tot_Drug_Cst)2019 Drug cost: $248,135 (USD; Tot_Drug_Cst)2020 Drug cost: $274,507 (USD; Tot_Drug_Cst)2021 Drug cost: $331,747 (USD; Tot_Drug_Cst)2022 Drug cost: $302,916 (USD; Tot_Drug_Cst)2023 Drug cost: $390,694 (USD; Tot_Drug_Cst)2024 Drug cost: $600,445 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015192591$43,698
2016272822$69,902
20173261,007$120,725
20183711,046$160,831
20194011,015$248,135
20203691,046$274,507
20214621,215$331,747
20225021,452$302,916
20234811,372$390,694
20245151,590$600,445

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths244301$79
11102Biopsy of related skin growth, first growth173194$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more692961$61
17000Destruction of precancer skin growth, 1 growth488612$40
17003Destruction of precancer skin growth, 2-14 growths3812,219$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast23810$130,877
Clobetasol PropionateClobetasol Propionate2105,088$6,343
TacrolimusTacrolimus842,127$5,469
FluocinonideFluocinonide1613,956$5,044
Doxycycline HyclateDoxycycline Hyclate705,648$2,562

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$48ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rany Jazayerli, M.D.?

Tedicare shows public-source Medicare data for Rany Jazayerli, M.D. (NPI 1831197995), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rany Jazayerli, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rany Jazayerli, M.D.?

Rany Jazayerli, M.D. is linked to WEST SUBURBAN DERMATOLOGY & COSMETIC SURGERY (billing NPI 1477617207) in the available physician profile data.

Does Rany Jazayerli, M.D. have Open Payments data?

Rany Jazayerli, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.